PRTA earnings call for the period ending December 31, 2019.
News & Analysis: Prothena
Shares plunge after the company announces that it is halting development of its lead pipeline candidate. Here's what investors need to know.
The company's landed a new collaboration partner and a new investor.
A sudden executive departure leaves Prothena's shareholders worried.
An advancing pipeline of drugs targeting important diseases could provide market-moving news over the coming year.